Profile: Iomed Inc manufactures active drug delivery systems in the physical and occupational therapy. We develop products for transdermal drug delivery and treatment of ophthalmic disease. We market iontophoresis electrodes, iontophoresis patches and dose controllers.
The company was founded in 1974, has revenues of USD 10-25 Million, has ~50 employees and is ISO 9001, CE certified. AMEX:IOX (SEC Filings)
5 Products/Services (Click for related suppliers)
|
• Electrotherapy Kits |
• Iontophoresis |
• Iontophoresis Device (FDA Code: KTB / 890.5525) An iontophoresis device is a device that is intended to use a direct current to introduce ions of soluble salts or other drugs into the body and induce sweating for use in the diagnosis of cystic fibrosis or for other uses if the labeling of the drug intended for use with the device bears adequate directions for the device's use with that drug. When used in the diagnosis of cystic fibrosis, the sweat is collected and its composition and weight are determined. |
• Non-invasive Drug Delivery System |
• Unit-Dose Drug Delivery System |